|
|
|
|
|
|
|
|
|
|
|
|
|
|
Previous: MEDICIS PHARMACEUTICAL CORP, 10-Q, 2000-11-14 |
Next: TRIDENT MICROSYSTEMS INC, 10-Q, 2000-11-14 |
<TABLE> <S> <C>
<ARTICLE> 5
<S> <C>
<PERIOD-TYPE> 3-MOS
<FISCAL-YEAR-END> JUN-30-2001
<PERIOD-START> JUL-01-2000
<PERIOD-END> SEP-30-2000
<CASH> 159,390,888
<SECURITIES> 145,046,150
<RECEIVABLES> 36,588,534
<ALLOWANCES> 4,390,000
<INVENTORY> 9,188,686
<CURRENT-ASSETS> 362,648,558
<PP&E> 2,969,797
<DEPRECIATION> 1,102,017
<TOTAL-ASSETS> 508,492,890
<CURRENT-LIABILITIES> 39,013,441
<BONDS> 0
0
0
<COMMON> 420,173
<OTHER-SE> 453,699,266
<TOTAL-LIABILITY-AND-EQUITY> 508,492,890
<SALES> 40,254,424
<TOTAL-REVENUES> 40,254,424
<CGS> 7,479,791
<TOTAL-COSTS> 7,479,791
<OTHER-EXPENSES> 36,329,918
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (4,357,413)
<INCOME-PRETAX> 802,128
<INCOME-TAX> 284,756
<INCOME-CONTINUING> 517,372
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> 517,372
<EPS-BASIC> 0.02
<EPS-DILUTED> 0.02
</TABLE>
|
|